Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lanoxin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lanoxin 125 tablets
0201010F0BBAAAE
|
Lanoxin | Digoxin | Cardiovascular System | 291 |
|
Lanoxin 250microgram tablets
0201010F0BBABAF
|
Lanoxin | Digoxin | Cardiovascular System | 140 |
|
Lanoxin PG 62.5microgram tablets
0201010F0BBADAD
|
Lanoxin | Digoxin | Cardiovascular System | 117 |
|
Lanoxin PG 50micrograms/ml elixir
0201010F0BBAEAA
|
Lanoxin | Digoxin | Cardiovascular System | 45 |
|
Lanoxin 500micrograms/2ml solution for infusion ampoules
0201010F0BBACAC
|
Lanoxin | Digoxin | Cardiovascular System | No data available |
|
Lanoxin Injection Pediatric 100micrograms/1ml inj ampoules
0201010F0BBAGAR
|
Lanoxin | Digoxin | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.